Key facts
- Xeos (Therapeutic Devices)’s last known valuation is $39.7M (Jan 2026).
- It has raised $30.3M; the latest was Accelerator/Incubator in Apr 2026.
- Notable investors include ARC Innovation Center.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Xeos (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Xeos (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xeos (Therapeutic Devices)
Developer of medical devices and equipment designed to improve surgical oncology outcomes. The company's devices specialize in providing treatment for breast-conserving surgery, prostate cancer surgery, and head and neck cancer surgery, enabling surgeons to speed up procedure time, reduce anesthesia time, and improve the chances of recovery.
- Sector
- Healthcare
- HQ
- Ghent, Belgium
- Founded
- 2019
- Employees
- 31
- Website
- xeos.care/
- Ownership
- Privately Held (backing)
Xeos (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xeos (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xeos (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.